US Bancorp’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

US Bancorp’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,156	Closed	-$138K	–	3747
2014 Q4	$138K	Buy	+8,156	New	+$115K	﹤0.01%	1951

US Bancorp's AVNR Position: Q1 2015 in Review

US Bancorp sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 8,156 shares — an estimated $138K sold.

US Bancorp first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $138K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

US Bancorp reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
US Bancorp sold 8,156 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $138K.
US Bancorp first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
US Bancorp's AVANIR PHARMACEUTICALS, INC CL A position peaked at $138K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on US Bancorp's 13F filing for Q1 2015, filed 8 May 2015.